Hexokinase 2 in cancer: a prima donna playing multiple characters

F Ciscato, L Ferrone, I Masgras, C Laquatra… - International journal of …, 2021 - mdpi.com
Hexokinases are a family of ubiquitous exose-phosphorylating enzymes that prime glucose
for intracellular utilization. Hexokinase 2 (HK2) is the most active isozyme of the family …

[HTML][HTML] Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer

M Liao, D Yao, L Wu, C Luo, Z Wang, J Zhang… - … Pharmaceutica Sinica B, 2024 - Elsevier
Cancer reprogramming is an important facilitator of cancer development and survival, with
tumor cells exhibiting a preference for aerobic glycolysis beyond oxidative phosphorylation …

[HTML][HTML] Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα

D Guo, Y Tong, X Jiang, Y Meng, H Jiang, L Du, Q Wu… - Cell metabolism, 2022 - cell.com
High expression of PD-L1 in tumor cells contributes to tumor immune evasion. However,
whether PD-L1 expression in tumor cells is regulated by the availability of nutrients is …

Targeting glucose metabolism enzymes in cancer treatment: current and emerging strategies

Y Zhang, Q Li, Z Huang, B Li, EC Nice, C Huang, L Wei… - Cancers, 2022 - mdpi.com
Simple Summary Reprogramming of glucose metabolism is a hallmark of cancer and can be
targeted by therapeutic agents. Some metabolism regulators, such as ivosidenib and …

Metabolic reprogramming in cancer: Mechanisms and therapeutics

S Nong, X Han, Y **ang, Y Qian, Y Wei, T Zhang… - MedComm, 2023 - Wiley Online Library
Cancer cells characterized by uncontrolled growth and proliferation require altered
metabolic processes to maintain this characteristic. Metabolic reprogramming is a process …

Knockdown of circDENND4C inhibits glycolysis, migration and invasion by up-regulating miR-200b/c in breast cancer under hypoxia

S Ren, J Liu, Y Feng, Z Li, L He, L Li, X Cao… - Journal of experimental …, 2019 - Springer
Background Hypoxia is a key feature of breast cancer, which affects cancer development,
metastasis and metabolism. Previous studies suggested that circular RNAs (circRNAs) could …

Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment

H Zhang, S Li, D Wang, S Liu, T **ao, W Gu, H Yang… - Biomarker …, 2024 - Springer
Tumor cells possess complex immune evasion mechanisms to evade immune system
attacks, primarily through metabolic reprogramming, which significantly alters the tumor …

Functional roles of lncRNA-TUG1 in hepatocellular carcinoma

M Farzaneh, M Ghasemian, F Ghaedrahmati… - Life Sciences, 2022 - Elsevier
Hepatocellular carcinoma (HCC) or hepatoma is malignant cancer that starts from the main
liver cells. Although various classical methods have been used for patients with HCC …

Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer

S Liu, X Zhang, W Wang, X Li, X Sun, Y Zhao, Q Wang… - Molecular Cancer, 2024 - Springer
Metabolic alterations, a hallmark of cancer, enable tumor cells to adapt to their environment
by modulating glucose, lipid, and amino acid metabolism, which fuels rapid growth and …

LINC00242/miR-1-3p/G6PD axis regulates Warburg effect and affects gastric cancer proliferation and apoptosis

P Deng, K Li, F Gu, T Zhang, W Zhao, M Sun, B Hou - Molecular Medicine, 2021 - Springer
Background Reprogrammed glucose metabolism of enhanced Warburg effect (or aerobic
glycolysis) is considered as a hallmark of cancer. Long non-coding RNAs (lncRNAs) have …